Insider Transactions Reported by 25 Insiders of Passage BIO, Inc.

Symbol
PASG on Nasdaq
Location
Philadelphia, PA

Insiders trading volume in the past year

Passage BIO, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lynx1 Capital Management LP 10%+ Owner $4,359,379 +$223,735 +5.4% 11 Sep 2025
ORBIMED ADVISORS LLC 10%+ Owner $2,001,893 -$325,674 -14% 24 Jun 2025
Jill M. Quigley Chief Operating Officer $338,849 08 Dec 2021
William Chou PRESIDENT AND CEO, Director $58,650 08 Jan 2026
Mark S. Forman Chief Medical Officer $56,272 15 Mar 2024
Alexandros Fotopoulos Chief Technical Officer $48,861 15 Jun 2023
Kathleen Borthwick Cfo $48,563 08 Jan 2026
Simona King Chief Financial Officer $21,835 28 Jul 2023
Monika Maria Toernsen Chief Commercial Officer $16,670 15 Sep 2022
Richard Steven Morris Chief Financial Officer $4,963 21 May 2021
Eliseo Oreste Salinas Chief Res. & Develop Officer 10 Feb 2022
Athena Countouriotis Director 28 May 2025
Maxine Gowen Director 28 May 2025
Brian Burkavage Controller 30 May 2021
Liam Ratcliffe Director 27 May 2021
Derrell Porter Director 28 May 2025
Thomas Richard Kassberg Director 28 May 2025
Michael E. Kamarck Director 25 May 2023
Bruce A. Goldsmith CEO and President, Director 27 May 2022
Thomas Woiwode Director, 10%+ Owner 25 May 2023
Saqib Islam Director 28 May 2025
Sandip Kapadia Director 28 May 2025
Dolan Sondhi Director 28 May 2025
Edgar B. Cale Gc & Corporate Secretary 15 Mar 2025
Tadataka Yamada Director 27 May 2021

Recent Insider Transactions by Companies or Individuals for Passage BIO, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
William Chou PASG Common Stock Sale -38.4% -4,076 6,524 08 Jan 2026 Direct
William Chou PASG Common Stock Options Exercise 1666.7% 10,000 10,600 08 Jan 2026 Direct
William Chou PASG Restricted Stock Unit Options Exercise -50% -10,000 10,000 08 Jan 2026 Direct
Kathleen Borthwick PASG Common Stock Sale -27.6% -2,062 5,402 08 Jan 2026 Direct
Kathleen Borthwick PASG Common Stock Options Exercise 202.9% 5,000 7,464 08 Jan 2026 Direct
Kathleen Borthwick PASG Restricted Stock Unit Options Exercise -50% -5,000 5,000 08 Jan 2026 Direct
Lynx1 Capital Management LP PASG Common Stock Purchase 1.95% $83,175 $6.99 11,900 623,704 15 Sep 2025 See footnote
Lynx1 Capital Management LP PASG Common Stock Purchase 3.34% $138,299 $6.99 19,783 611,804 12 Sep 2025 See footnote
Lynx1 Capital Management LP PASG Common stock, $0.0001 par value per share (Common Stock) Purchase 0.05% $2,261 $6.96 325 592,021 11 Sep 2025 See footnote
Lynx1 Capital Management LP PASG Common Stock Purchase 12.6% 66,423 591,696 24 Jul 2025 See footnote
Lynx1 Capital Management LP PASG Common Stock Purchase 10.4% 49,302 525,273 23 Jul 2025 See footnote
Lynx1 Capital Management LP PASG Common stock, $0.0001 par value per share ("Common Stock") Purchase 2.84% 13,123 475,971 22 Jul 2025 See footnote
Orbimed Advisors Llc PASG Common Stock Sale -3.4% $70,375 $0.3300 -213,257 6,066,343 26 Jun 2025 See footnotes
Orbimed Advisors Llc PASG Common Stock Sale -2.16% $45,804 $0.3300 -138,800 6,279,600 25 Jun 2025 See footnotes
Orbimed Advisors Llc PASG Common Stock Sale -3.48% $81,060 $0.3500 -231,600 6,418,400 24 Jun 2025 See footnotes
Sandip Kapadia PASG Director Stock Option (right to buy) Award 201,857 201,857 28 May 2025 Direct
Maxine Gowen PASG Director Stock Option (right to buy) Award 201,857 201,857 28 May 2025 Direct
Athena Countouriotis PASG Director Stock Option (right to buy) Award 201,857 201,857 28 May 2025 Direct
Derrell Porter PASG Director Stock Option (right to buy) Award 201,857 201,857 28 May 2025 Direct
Saqib Islam PASG Director Stock Option (right to buy) Award 201,857 201,857 28 May 2025 Direct
Dolan Sondhi PASG Director Stock Option (right to buy) Award 201,857 201,857 28 May 2025 Direct
Thomas Richard Kassberg PASG Director Stock Option (right to buy) Award 143,789 143,789 28 May 2025 Direct
Orbimed Advisors Llc PASG Common Stock Sale -1.02% $21,822 $0.3200 -68,195 6,650,000 24 Apr 2025 See footnotes
Orbimed Advisors Llc PASG Common Stock Sale -1.31% $30,372 $0.3400 -89,328 6,718,195 23 Apr 2025 See footnotes
Orbimed Advisors Llc PASG Common Stock Sale -1.13% $26,537 $0.3400 -78,049 6,807,523 22 Apr 2025 See footnotes
Orbimed Advisors Llc PASG Common Stock Sale -1.11% $25,440 $0.3300 -77,090 6,885,572 17 Apr 2025 See footnotes
Orbimed Advisors Llc PASG Common Stock Sale -0.88% $20,341 $0.3300 -61,638 6,962,662 16 Apr 2025 See footnotes
Orbimed Advisors Llc PASG Common Stock Sale -0.15% $3,924 $0.3800 -10,326 7,024,300 15 Apr 2025 See footnotes
* An asterisk sign (*) next to the price indicates that the price is likely invalid.